BioCardia Inc
NASDAQ:BCDA

Watchlist Manager
BioCardia Inc Logo
BioCardia Inc
NASDAQ:BCDA
Watchlist
Price: 1.27 USD
Market Cap: 13.5m USD

Relative Value

There is not enough data to reliably calculate the relative value of BCDA.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BCDA Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
11
Median 3Y
172.9
Median 5Y
393.3
Industry
7.9
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-29.7
Industry
23.7
Forward
-1.1
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-34.2
Industry
22
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-33.8
Industry
24.3
vs History
63
vs Industry
23
Median 3Y
3.9
Median 5Y
47.3
Industry
3.3
vs History
vs Industry
12
Median 3Y
120.3
Median 5Y
388.2
Industry
8.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.2
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-29.3
Industry
6.1
Forward
-0.9
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-29.1
Industry
6.5
Forward
-1
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-33.3
Industry
7.9
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-33
Industry
6.3
vs History
vs Industry
21
Median 3Y
22.7
Median 5Y
225.9
Industry
5.7

Multiples Across Competitors

BCDA Competitors Multiples
BioCardia Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
BioCardia Inc
NASDAQ:BCDA
13.5m USD 0 -1.5 -0.9 -0.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 686 905 -160 108.9 -194 423.2 -192 204.6
US
Abbvie Inc
NYSE:ABBV
406.8B USD 6.8 173.5 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
178.8B USD 5 25.5 18.4 18.4
US
Gilead Sciences Inc
NASDAQ:GILD
155.2B USD 5.3 19.1 12.9 12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.4B USD 10 31.9 23.5 24.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 091.3 -533.6 -581.1 -565.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.4B USD 5.8 18 17.2 19.5
AU
CSL Ltd
ASX:CSL
84B AUD 3.6 18.8 12.7 15.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.8B USD 16.5 1 212.8 163.5 198.3
NL
argenx SE
XBRU:ARGX
43.9B EUR 14.4 33.7 58.2 59.8
P/S Multiple
Revenue Growth P/S to Growth
US
BioCardia Inc
NASDAQ:BCDA
Average P/S: 3 368 906.4
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 686 905
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.8
9%
0.8
US
Amgen Inc
NASDAQ:AMGN
5
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.3
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10
10%
1
US
E
Epizyme Inc
F:EPE
2 091.3
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.8
6%
1
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.5
46%
0.4
NL
argenx SE
XBRU:ARGX
14.4
49%
0.3
P/E Multiple
Earnings Growth PEG
US
BioCardia Inc
NASDAQ:BCDA
Average P/E: 191.7
Negative Multiple: -1.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 108.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
173.5
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.5
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19.1
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.9
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
10%
1.8
AU
CSL Ltd
ASX:CSL
18.8
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 212.8
N/A N/A
NL
argenx SE
XBRU:ARGX
33.7
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
BioCardia Inc
NASDAQ:BCDA
Average EV/EBITDA: 40.4
Negative Multiple: -0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 423.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.4
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.2
11%
1.6
AU
CSL Ltd
ASX:CSL
12.7
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163.5
N/A N/A
NL
argenx SE
XBRU:ARGX
58.2
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
BioCardia Inc
NASDAQ:BCDA
Average EV/EBIT: 46.6
Negative Multiple: -0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 204.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.4
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.5
13%
1.5
AU
CSL Ltd
ASX:CSL
15.8
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
198.3
N/A N/A
NL
argenx SE
XBRU:ARGX
59.8
N/A N/A